TGFB1 and neoplasm: Furthermore, some components existing in the tumor microenvironment were also found to directly reduce the immune response against cancer, including prostaglandin E2, vascular endothelial growth factor, interleukin IL-10 secreted from cancer cells, and transforming growth factor-β (TGF-β) [23,24,25,26].